Search Results

Your search for Roy Decker, MD, PhD matches 2 pages

Showing 1 - 2

By Roy Decker, MD, PhD / 2015 ASTRO Annual Meeting

Roy Decker, MD, PhD, on Chemoradiation in Elderly Patients With Limited-Stage SCLC

Roy Decker, MD, PhD, of Yale University School of Medicine, discusses a National Cancer Database analysis that showed elderly patients with limited-stage small cell lung cancer can benefit from adding concurrent radiation to chemotherapy (Abstract 1010).

lung cancer

By Matthew Stenger / Friday, October 30, 2015 3:35 PM

Chemoradiotherapy Survival Benefit in Elderly Patients With Limited-Stage SCLC

In a population-based study reported in the Journal of Clinical Oncology, Corso et al found that chemoradiotherapy was associated with an overall survival benefit vs chemotherapy in elderly patients with limited-stage small cell lung cancer (SCLC). Study Details The study involved National Cancer ...

Apr

Today In Oncology

Search Results

Your search for Roy Decker, MD, PhD matches 2 pages

Roy Decker, MD, PhD, on Chemoradiation in Elderly Patients With Limited-Stage SCLC

Chemoradiotherapy Survival Benefit in Elderly Patients With Limited-Stage SCLC

Nivolumab With or Without Ipilimumab in Recurrent or Metastatic Cervical Cancer

Bispecific Immune Checkpoint Inhibitor Improves Survival in Patients With Gastric Cancer, Regardless of PD-L1 Status

Cabozantinib in Metastatic Pheochromocytomas or Paragangliomas

Propofol-Based Anesthesia May Offer Improved Detection of Serrated Polyps During Colonoscopy

Observing a Healthy Diet May Reduce Risk of Cardiovascular Disease in Breast Cancer Survivors